Medicine for treating yin-deficiency and dryness-heat type diabetic retinopathy and preparation method thereof

Abstract

The invention discloses a medicine for treating yin-deficiency and dryness-heat type diabetic retinopathy and a preparation method thereof. The active pharmaceutical ingredients of the medicine include fruticose breyniae leaf and twig, lac, procumbent indian mallow root, sea cucumber, stachys geobombycis, caragana microphylla, freshwater sponge, mulberry fruit, rhizoma polygonati, glossy privet fruit, pseudostellaria heterophylla, radix ophiopogonis, herba dendrobii, hippuris vulgaris, folium ilicis cornutae, callicarpa bodinieri, copperleaf herb, tree-of-heaven bark, cinnamomum burmanii bark, cattail pollen, discolor cinquefoil herb, silkworm excrement, herba siegesbeckiae, ash bark, berberis heteropoda, ciliate leucas, herb of marsh horsetail, herba scutellariae barbatae, cortex phellodendri, radix scutellariae, radix astragali, rhizoma dioscoreae and radix glycyrrhizae. The medicine disclosed by the invention has the functions of nourishing yin and clearing heat and stopping bleeding and resolving stasis, and is used for treating the yin-deficiency and dryness-heat type diabetic retinopathy; the preparation process is simple and convenient, few toxic and side effects are caused, the administration is convenient, the medicine is easy to prepare, and the cost is low; the traditional Chinese medicinal materials with different properties are adopted, and an ideal treatment effect can be realized through scientific compatibility; and moreover, the medicine is safe and easy to prepare and can reach the focus directly while the healing time is short and the disease rarely relapses after being healed.

Description

technical field [0001] The invention relates to a medical preparation containing raw materials derived from plants, animals or minerals, in particular to a medicine for treating diabetic retinopathy and a preparation method thereof. Background technique [0002] Diabetic retinopathy (DR) is the most important manifestation of diabetic microangiopathy, a fundus lesion with specific changes, and one of the serious complications of diabetes. Clinically, based on the presence or absence of retinal neovascularization as a sign, diabetic retinopathy without retinal neovascularization is called non-proliferative diabetic retinopathy (NPDR) (or simple type or background type), while retinal neovascularization will be The resulting diabetic retinopathy is called proliferative diabetic retinopathy (PDR). [0003] In economically developed countries, diabetic retinopathy is a major cause of blindness. Generally speaking, about one quarter of diabetic patients have diabetic retinopat...

AI Technical Summary

Problems solved by technology

[0015] However, the cost of Western medicine surgical treatment is high, and patients are not easy to accept it. Western medicine treatment has large toxic and side effects, and it is easy to relapse.